Notification of Issue, Conversion or Payment up of Unquoted Equity SecuritiesAnnouncement Summary
Entity name
For personal use only
LUMOS DIAGNOSTICS HOLDINGS LIMITED
Date of this announcement Friday April 01, 2022
The +securities the subject of this notification are:
+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX
Total number of +securities to be issued/transferred
ASX +security | +securities to be | ||
code | Security description | issued/transferred | Issue date |
LDXAG | OPTION EXPIRING 30-JUN-2025 EX $1.25 | 321,514 | 01/04/2022 |
Refer to next page for full details of the announcement
Total number of
1 / 6
Notification of Issue, Conversion or Payment up of Unquoted Equity SecuritiesPart 1 - Entity and announcement details
For personal use only
1.1 Name of entity
LUMOS DIAGNOSTICS HOLDINGS LIMITED
We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.
1.2 Registered number type ACN
1.3 ASX issuer code LDX
1.4 The announcement isNew announcement
1.5 Date of this announcement 1/4/2022
Registration number 630476970
2 / 6
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 2 - Issue details
2.1 The +securities the subject of this notification are:
+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX
For personal use only
2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:has an existing ASX security code ("existing class")
3 / 6
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to ASX in an Appendix 3B
For personal use only
ASX +security code and description
LDXAG : OPTION EXPIRING 30-JUN-2025 EX $1.25
Date the +securities the subject of this notification were issued 1/4/2022
Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class
Yes
Were any of the +securities issued to +key management personnel (KMP) or an +associate?
No
Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms
https://lumosdiagnostics.com/wp-content/uploads/2021/07/2229702.pdf
Any other information the entity wishes to provide about the +securities the subject of this notification
Issue details
Number of +securities
321,514
4 / 6
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 4 - +Securities on issue
For personal use only
Following the issue, conversion or payment up of the +securities the subject of this application, the +securities of the entity will comprise:
(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)
4.1 Quoted +Securities (Total number of each +class of +securities quoted)
Total number ofASX +security code and description
+securities on issue
LDX : ORDINARY FULLY PAID
150,776,978
4.2 Unquoted +Securities (Total number of each +class of +securities issued but not quoted on ASX)
Total number of
ASX +security code and description | +securities on issue |
LDXAF : OPTION EXPIRING 01-JUN-2024 EX $1.25 | 120,000 |
LDXAH : OPTION EXPIRING 15-NOV-2026 EX $0.80 | 10,000 |
LDXAG : OPTION EXPIRING 30-JUN-2025 EX $1.25 | 3,860,938 |
LDXAA : OPTION EXPIRING 12-AUG-2026 EX $0.57 | 8,559,731 |
LDXAB : OPTION EXPIRING 04-NOV-2026 EX $0.57 | 457,431 |
LDXAC : OPTION EXPIRING 02-MAR-2027 EX $0.57 | 320,202 |
LDXAD : OPTION EXPIRING 04-MAR-2027 EX $0.57 | 137,229 |
LDXAE : OPTION EXPIRING 01-OCT-2027 EX $0.57 | 853,602 |
Notification of Issue, Conversion or Payment up of Unquoted | |
Equity Securities |
5 / 6
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Lumos Diagnostics Holdings Ltd. published this content on 01 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 April 2022 03:52:34 UTC.